Table 2.
Virus | ICPI scorea | MDT (h)b |
---|---|---|
rLaSota | 0.00 | >120 |
rLaSGNP | 0.00 | >120 |
rLaSGP | 0.00 | >120 |
rLaSGL | 0.00 | >120 |
rLaSGNPP | 0.34ˆ** | >120 |
rLaSGNPL | 0.14ˆ* | >120 |
rLaSGPL | 0.12ˆ* | >120 |
rLaSGNPPL | 0.63ˆ*** | >120 |
rSG10 | 1.86 | 57 |
rSGLaNP | 1.78 | 72∗∗ |
rSGLaP | 1.89 | 52 |
rSGLaL | 1.68ˆ** | 83∗∗∗ |
rSGLaNPP | 1.90 | 58 |
rSGLaNPL | 1.48ˆ*** | 86∗∗∗ |
rSGLaPL | 1.40ˆ*** | 84∗∗∗ |
rSGLaNPPL | 1.32ˆ*** | 89∗∗∗ |
aPathotype definitions by ICPI: virulent strains, 1.50–2.00; moderately virulent strains, 0.70–1.50; avirulent strains, 0.00–0.70. bPathotype definitions by MDT: virulent strains, <60 h; moderately virulent strains, 60–90 h; avirulent strains, >90 h. Asterisks indicate the statistical significance of the ICPI score and MDT of a chimeric virus compared to the parental virus of that group. P-values were calculated based on a two-tailed, unpaired t test (95% confidence levels). ∗p = 0.01–0.05, significant; ∗∗p = 0.001–0.01, very significant; ∗∗∗p = 0.0001–0.001, extremely significant.